Federal contract award
N0042125F0819
LABOR - TRAINING AND SYSTEMS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NAVAL AIR WARFARE CENTER AIR DIV |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | N0042125D0303 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $18.3M |
| Current contract value | $35.2M |
| Potential contract value / ceiling | $98.8M |
| Start date | Jun 30, 2025 |
| Current end date | Jun 30, 2026 |
| Potential end date | Jun 30, 2030 |
| Latest award activity | Jun 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 9, 2026 | P00014 | $238.5K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0101 AND 0102. |
| Apr 20, 2026 | P00013 | $308.0K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001 AND 0002. |
| Apr 1, 2026 | P00012 | $1.4M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001, 0002, AND 0003. |
| Feb 23, 2026 | P00011 | $92.1K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001. |
| Jan 12, 2026 | P00010 | $1.1M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001, 0002 AND 0003. |
| Dec 11, 2025 | P00009 | $28.0K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0002. |
| Nov 21, 2025 | P00008 | $151.6K | IF |
| Nov 5, 2025 | P00007 | $171.5K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001. |
| Oct 15, 2025 | P00006 | $2.8M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001 AND 0002, PLUS ADD IN THE OPTION YEARS. |
| Sep 25, 2025 | P00005 | $593.8K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001 AND 0003. |
| Sep 24, 2025 | P00004 | $92.2K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001. |
| Sep 10, 2025 | P00003 | $256.4K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001 AND 0003. |
| Aug 26, 2025 | P00002 | $400.3K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001, CHANGE THE UNFUNDED CLIN TO OPTION AND ADD THE DATA CLIN. |
| Aug 11, 2025 | P00001 | $2.2M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0001 AND 0002. |
| Jun 26, 2025 | 0 | $2.5M | LABOR - TRAINING AND SYSTEMS |
Estimated positioning window
Jun 30, 2029 – Dec 30, 2029
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2030-06-30 (1337 days from calculation)
- +5 points
- 21 historical awards in this buyer and category group
- +15 points
- 15 recorded award transactions
- +10 points
- Latest award action: 2026-06-09
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.